首页 > 最新文献

Clinical Pediatric Endocrinology最新文献

英文 中文
COL10A1-related metaphyseal dysplasia Schmid caused by the p.L644F variant in the COL10A1 gene. COL10A1基因p.L644F变异引起的COL10A1相关干骺端发育不良。
IF 1.2 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-10-01 Epub Date: 2025-06-10 DOI: 10.1297/cpe.2025-0037
Tomoyuki Ito, Yurika Senoo, Takahiro Shindo, Yoshiyuki Namai, Yoichiro Oda
{"title":"<i>COL10A1</i>-related metaphyseal dysplasia Schmid caused by the p.L644F variant in the <i>COL10A1</i> gene.","authors":"Tomoyuki Ito, Yurika Senoo, Takahiro Shindo, Yoshiyuki Namai, Yoichiro Oda","doi":"10.1297/cpe.2025-0037","DOIUrl":"10.1297/cpe.2025-0037","url":null,"abstract":"","PeriodicalId":10678,"journal":{"name":"Clinical Pediatric Endocrinology","volume":"34 4","pages":"280-283"},"PeriodicalIF":1.2,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12494397/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145231680","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A 14-yr-old boy with a pathogenic MEN1 variant was diagnosed with asymptomatic insulinoma during routine follow-up. 一名14岁男孩在常规随访中被诊断为无症状胰岛素瘤。
IF 1.2 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-10-01 Epub Date: 2025-06-26 DOI: 10.1297/cpe.2025-0027
Risa Yokoyama, Takumi Shibazaki, Chizuko Nakamura, Haruka Morota, Yozo Nakazawa

Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disorder attributed to mutations in the MEN1 gene and is characterized by multiple endocrine tumors, including insulinoma. Asymptomatic hyperinsulinemic hypoglycemia and pancreatic nodules were incidentally detected in a 14-yr-old male carrying a pathogenic MEN1 variant. Although insulinoma was suspected, it did not meet Whipple's triad, the classic diagnostic criteria for insulinoma, and some hypoglycemic provocation tests were negative. Selective arterial secretagogue injection (SASI) testing strongly suggested the presence of an insulinoma, and the lesions were surgically excised. The pathological findings were consistent with the SASI test results. Diagnosis of insulinoma based on conventional tests is challenging in some patients with asymptomatic insulinoma, and SASI testing can be useful not only for localization but also for insulinoma diagnosis.

多发性内分泌肿瘤1型(MEN1)是一种常染色体显性遗传病,由MEN1基因突变引起,以包括胰岛素瘤在内的多发性内分泌肿瘤为特征。在一名携带致病性MEN1变异的14岁男性中偶然发现无症状高胰岛素性低血糖和胰腺结节。虽然怀疑是胰岛素瘤,但不符合惠普尔三联征,即胰岛素瘤的经典诊断标准,而且一些低血糖激发试验呈阴性。选择性动脉促分泌剂注射(SASI)检测强烈提示存在胰岛素瘤,并手术切除病变。病理结果与SASI检查结果一致。在一些无症状的胰岛素瘤患者中,基于常规检查的胰岛素瘤诊断是具有挑战性的,而SASI检测不仅可以用于定位,而且可以用于胰岛素瘤的诊断。
{"title":"A 14-yr-old boy with a pathogenic <i>MEN1</i> variant was diagnosed with asymptomatic insulinoma during routine follow-up.","authors":"Risa Yokoyama, Takumi Shibazaki, Chizuko Nakamura, Haruka Morota, Yozo Nakazawa","doi":"10.1297/cpe.2025-0027","DOIUrl":"10.1297/cpe.2025-0027","url":null,"abstract":"<p><p>Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disorder attributed to mutations in the <i>MEN1</i> gene and is characterized by multiple endocrine tumors, including insulinoma. Asymptomatic hyperinsulinemic hypoglycemia and pancreatic nodules were incidentally detected in a 14-yr-old male carrying a pathogenic <i>MEN1</i> variant. Although insulinoma was suspected, it did not meet Whipple's triad, the classic diagnostic criteria for insulinoma, and some hypoglycemic provocation tests were negative. Selective arterial secretagogue injection (SASI) testing strongly suggested the presence of an insulinoma, and the lesions were surgically excised. The pathological findings were consistent with the SASI test results. Diagnosis of insulinoma based on conventional tests is challenging in some patients with asymptomatic insulinoma, and SASI testing can be useful not only for localization but also for insulinoma diagnosis.</p>","PeriodicalId":10678,"journal":{"name":"Clinical Pediatric Endocrinology","volume":"34 4","pages":"240-248"},"PeriodicalIF":1.2,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12497574/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145243848","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Van Wyk-Grumbach syndrome: a case report and review of the literature. Van Wyk-Grumbach综合征1例报告及文献复习。
IF 1.2 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-10-01 Epub Date: 2025-08-10 DOI: 10.1297/cpe.2025-0032
Yosuke Komatsu, Nobuyuki Kikuchi

Van Wyk-Grumbach syndrome (VWGS) is a rare manifestation of acquired hypothyroidism that was first described in 1960. It is characterized by precocious puberty, delayed bone age, and, in some cases, galactorrhea. We report the case of a 9-yr-old girl with growth retardation, delayed bone age, and vaginal bleeding without pubic hair development. Laboratory tests showed severe hypothyroidism (TSH level: 1,805 µIU/mL; free T4: 0.1 ng/dL), suppressed LH level, elevated estradiol (53 pg/mL) level, and hyperprolactinemia (59.79 ng/mL). Bilateral ovarian cysts were observed. Levothyroxine normalized thyroid function and reduced the number of cysts; however, central puberty progressed within 5 mo, requiring GnRH analog therapy. A review of 44 previously reported female patients revealed consistent findings including delayed bone age, elevated TSH level, suppressed gonadotropin levels, and frequent vaginal bleeding despite the absence of pubic hair. This atypical sequence likely resulted from TSH-induced estradiol secretion without concurrent adrenal androgen activity. This atypical pubertal development sequence may serve as a useful clinical indicator of VWGS. Assessment of thyroid function is warranted in young girls presenting with isolated vaginal bleeding in the absence of pubic hair, not only to avoid misdiagnosis, but more importantly, to ensure the timely initiation of appropriate treatment for underlying hypothyroidism.

Van Wyk-Grumbach综合征(VWGS)是一种罕见的获得性甲状腺功能减退症的表现,于1960年首次被描述。它的特点是性早熟,骨龄延迟,在某些情况下,还会有溢乳。我们报告的情况下,9岁的女孩生长迟缓,延迟骨龄,阴道出血无阴毛发育。实验室检查显示严重甲状腺功能减退(TSH水平:1,805 μ IU/mL;游离T4: 0.1 ng/dL), LH水平抑制,雌二醇水平升高(53 pg/mL),高催乳素血症(59.79 ng/mL)。双侧卵巢囊肿。左旋甲状腺素使甲状腺功能正常化,减少囊肿数量;然而,中枢性青春期在5个月内进展,需要GnRH模拟治疗。对先前报道的44例女性患者的回顾显示了一致的结果,包括骨龄延迟,TSH水平升高,促性腺激素水平抑制,尽管没有阴毛,但阴道出血频繁。这种非典型序列可能是由于tsh诱导的雌二醇分泌而没有肾上腺雄激素活性。这种不典型的青春期发育顺序可以作为VWGS的一个有用的临床指标。在没有阴毛的情况下,对出现孤立性阴道出血的年轻女孩进行甲状腺功能评估是必要的,这不仅是为了避免误诊,更重要的是,为了确保及时开始适当的治疗潜在的甲状腺功能减退。
{"title":"Van Wyk-Grumbach syndrome: a case report and review of the literature.","authors":"Yosuke Komatsu, Nobuyuki Kikuchi","doi":"10.1297/cpe.2025-0032","DOIUrl":"10.1297/cpe.2025-0032","url":null,"abstract":"<p><p>Van Wyk-Grumbach syndrome (VWGS) is a rare manifestation of acquired hypothyroidism that was first described in 1960. It is characterized by precocious puberty, delayed bone age, and, in some cases, galactorrhea. We report the case of a 9-yr-old girl with growth retardation, delayed bone age, and vaginal bleeding without pubic hair development. Laboratory tests showed severe hypothyroidism (TSH level: 1,805 µIU/mL; free T4: 0.1 ng/dL), suppressed LH level, elevated estradiol (53 pg/mL) level, and hyperprolactinemia (59.79 ng/mL). Bilateral ovarian cysts were observed. Levothyroxine normalized thyroid function and reduced the number of cysts; however, central puberty progressed within 5 mo, requiring GnRH analog therapy. A review of 44 previously reported female patients revealed consistent findings including delayed bone age, elevated TSH level, suppressed gonadotropin levels, and frequent vaginal bleeding despite the absence of pubic hair. This atypical sequence likely resulted from TSH-induced estradiol secretion without concurrent adrenal androgen activity. This atypical pubertal development sequence may serve as a useful clinical indicator of VWGS. Assessment of thyroid function is warranted in young girls presenting with isolated vaginal bleeding in the absence of pubic hair, not only to avoid misdiagnosis, but more importantly, to ensure the timely initiation of appropriate treatment for underlying hypothyroidism.</p>","PeriodicalId":10678,"journal":{"name":"Clinical Pediatric Endocrinology","volume":"34 4","pages":"268-274"},"PeriodicalIF":1.2,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12494393/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145231461","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical factors associated with advanced glycation end-products (AGEs) levels evaluated by skin autofluorescence of schoolchildren in Japan. 日本学龄儿童皮肤自身荧光法评估晚期糖基化终产物(AGEs)水平的相关临床因素
IF 1 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-07-01 Epub Date: 2025-05-24 DOI: 10.1297/cpe.2024-0042
Keiko Nagahara, Sakura Motegi, Ayako Ochi, Junya Toyoda, Yuya Nakano, Takanori Imai, Masanori Adachi, Sho-Ichi Yamagishi, Katsumi Mizuno

Advanced glycation end-products (AGEs) formed by non-enzymatic glycation reactions between sugars and proteins have been implicated in various age-related disorders. Skin autofluorescence (SAF) is a noninvasive method for estimating the accumulated AGEs levels in the human body. However, the SAF values in healthy children have not yet been reported. This study aimed to determine reference values and factors affecting SAF values in apparently healthy schoolchildren. The study included 426 children (aged 8.9 ± 1.7 yr), including 224 boys and 202 girls from one public elementary school. SAF values were measured using an AGE reader. Data on the perinatal history, eating and exercise habits, lifestyle, family background, and medical history of the participants and their family medical history were collected using a questionnaire. The mean SAF value of the participants was 1.06 ± 0.19 AU, lower than that of healthy adults, and did not increase with calendar age. Moreover, a family history of diabetes within second-degree relatives was the sole significant factor associated with SAF values (p = 0.045), and it exhibited no association with life environmental factors. In conclusion, genetically defined susceptibility to glycation may be the most important factor in AGE accumulation in schoolchildren.

糖和蛋白质之间的非酶糖基化反应形成的晚期糖基化终产物(AGEs)与各种年龄相关疾病有关。皮肤自体荧光法(SAF)是一种非侵入性测定人体AGEs累积水平的方法。然而,健康儿童的SAF值尚未报道。本研究旨在确定表面健康学童SAF值的参考值及影响因素。研究对象为一所公立小学的426名儿童(年龄8.9±1.7岁),其中男孩224名,女孩202名。使用AGE阅读器测量SAF值。采用问卷调查的方式收集参与者的围产期、饮食和运动习惯、生活方式、家庭背景、病史及家庭病史等资料。受试者的平均SAF值为1.06±0.19 AU,低于健康成人,且不随年龄增长而增加。此外,二度亲属中有糖尿病家族史是唯一与SAF值相关的显著因素(p = 0.045),与生活环境因素无相关性。总之,遗传上确定的糖基化易感性可能是学龄期儿童AGE积累的最重要因素。
{"title":"Clinical factors associated with advanced glycation end-products (AGEs) levels evaluated by skin autofluorescence of schoolchildren in Japan.","authors":"Keiko Nagahara, Sakura Motegi, Ayako Ochi, Junya Toyoda, Yuya Nakano, Takanori Imai, Masanori Adachi, Sho-Ichi Yamagishi, Katsumi Mizuno","doi":"10.1297/cpe.2024-0042","DOIUrl":"10.1297/cpe.2024-0042","url":null,"abstract":"<p><p>Advanced glycation end-products (AGEs) formed by non-enzymatic glycation reactions between sugars and proteins have been implicated in various age-related disorders. Skin autofluorescence (SAF) is a noninvasive method for estimating the accumulated AGEs levels in the human body. However, the SAF values in healthy children have not yet been reported. This study aimed to determine reference values and factors affecting SAF values in apparently healthy schoolchildren. The study included 426 children (aged 8.9 ± 1.7 yr), including 224 boys and 202 girls from one public elementary school. SAF values were measured using an AGE reader. Data on the perinatal history, eating and exercise habits, lifestyle, family background, and medical history of the participants and their family medical history were collected using a questionnaire. The mean SAF value of the participants was 1.06 ± 0.19 AU, lower than that of healthy adults, and did not increase with calendar age. Moreover, a family history of diabetes within second-degree relatives was the sole significant factor associated with SAF values (p = 0.045), and it exhibited no association with life environmental factors. In conclusion, genetically defined susceptibility to glycation may be the most important factor in AGE accumulation in schoolchildren.</p>","PeriodicalId":10678,"journal":{"name":"Clinical Pediatric Endocrinology","volume":"34 3","pages":"162-171"},"PeriodicalIF":1.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12236184/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144599623","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Attitude survey on Japanese parents of children visiting the hospital for consultation on early puberty. 日本儿童家长赴医院咨询性早熟问题的态度调查
IF 1 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-07-01 Epub Date: 2025-04-10 DOI: 10.1297/cpe.2024-0102
Akiko Saito-Hakoda, Aki Nishii

Globally, the incidence of precocious puberty increases with a decline in age of pubertal onset. Simultaneously, the rate of hospital referrals for children in early puberty has increased. This study is the first survey of Japanese parents of children who visited a hospital for referral about early puberty to clarify their parents' concerns. We conducted a survey using an initial medical questionnaire between April 2019 and May 2023. In total, 230 parents completed the questionnaire during their first visit. Over half of the parents were concerned about puberty and desired aggressive treatment. The most common concerns were children's height prognosis and early menarche in girls. Psychological problems were relatively infrequent. Only 20% of children had indications for treatment. Our survey showed that many children were referred to our department preceded by their parents' excessive anxiety and quest for treatment. Psychological issues may not be a major determinant of an indication for therapy with central precocious puberty. Providing sufficient explanations and correct information on puberty is important to alleviate parental anxiety and reduce unnecessary referrals.

在全球范围内,性早熟的发病率随着青春期开始年龄的下降而增加。同时,青春期早期儿童的医院转诊率有所增加。这项研究是第一次对日本儿童父母进行调查,他们到医院转诊关于青春期提前的问题,以澄清父母的担忧。我们在2019年4月至2023年5月期间使用初步医疗问卷进行了调查。总共有230名家长在第一次访问期间完成了问卷。超过一半的家长担心孩子的青春期,希望得到积极的治疗。最常见的担忧是儿童的身高预后和女孩的早期月经初潮。心理问题相对较少。只有20%的儿童有治疗指征。我们的调查显示,许多儿童在他们的父母过度焦虑和寻求治疗之前被转介到我科。心理问题可能不是中枢性性早熟治疗指征的主要决定因素。提供充分的青春期解释和正确的信息对于减轻父母的焦虑和减少不必要的转诊是很重要的。
{"title":"Attitude survey on Japanese parents of children visiting the hospital for consultation on early puberty.","authors":"Akiko Saito-Hakoda, Aki Nishii","doi":"10.1297/cpe.2024-0102","DOIUrl":"10.1297/cpe.2024-0102","url":null,"abstract":"<p><p>Globally, the incidence of precocious puberty increases with a decline in age of pubertal onset. Simultaneously, the rate of hospital referrals for children in early puberty has increased. This study is the first survey of Japanese parents of children who visited a hospital for referral about early puberty to clarify their parents' concerns. We conducted a survey using an initial medical questionnaire between April 2019 and May 2023. In total, 230 parents completed the questionnaire during their first visit. Over half of the parents were concerned about puberty and desired aggressive treatment. The most common concerns were children's height prognosis and early menarche in girls. Psychological problems were relatively infrequent. Only 20% of children had indications for treatment. Our survey showed that many children were referred to our department preceded by their parents' excessive anxiety and quest for treatment. Psychological issues may not be a major determinant of an indication for therapy with central precocious puberty. Providing sufficient explanations and correct information on puberty is important to alleviate parental anxiety and reduce unnecessary referrals.</p>","PeriodicalId":10678,"journal":{"name":"Clinical Pediatric Endocrinology","volume":"34 3","pages":"180-187"},"PeriodicalIF":1.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12236187/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144599622","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management strategy for congenital hyperinsulinism with atrial septal defect and diazoxide-induced pulmonary hypertension. 先天性高胰岛素血症合并房间隔缺损和二氮唑所致肺动脉高压的治疗策略。
IF 1 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-07-01 Epub Date: 2025-04-18 DOI: 10.1297/cpe.2024-0096
Sayuri Koizumi, Ikuma Musha, Koichi Toda, Hiroshi Kawana, Chikahiko Numakura, Katsuhiko Tabata, Takamasa Mizumoto, Taisuke Nabeshima, Takuro Kojima, Toshiki Kobayashi, Takaya Hoashi, Toru Kikuchi

Congenital hyperinsulinism (CHI) is characterized by hypoglycemia caused by excessive insulin secretion. CHI is classified into two types: transient CHI, which resolves within 3-4 mo of birth, and persistent CHI, which persists beyond this period. Diazoxide, the first-line treatment for CHI, may cause pulmonary hypertension (PH) as a side effect. Here, we report the case of a 2-mo-old girl with CHI and an atrial septal defect who initially responded well to diazoxide but developed dose-dependent PH. Diazoxide was discontinued, and treatment was switched to octreotide, glycogen storage disease milk, and glucagon. However, maintaining stable blood glucose levels remained challenging. Surgical intervention is typically required when medical management is ineffective; however, such procedures are limited to specialized facilities. Additionally, pancreatic resection carries a high risk of postoperative diabetes. To enable the safe reintroduction of diazoxide, we surgically closed the atrial septal defect with a left-to-right shunt and combined diazoxide therapy with anti-PH medication. This approach successfully controlled PH and achieved good glycemic control.

先天性高胰岛素症(CHI)以胰岛素分泌过多引起低血糖为特征。CHI分为两种类型:一种是短暂性CHI,在出生后3-4个月内消失;另一种是持续性CHI,在出生后3-4个月后持续存在。二氮氧化合物作为CHI的一线治疗药物,其副作用可能导致肺动脉高压(PH)。在这里,我们报告了一个2岁大的患有CHI和房间隔缺损的女孩,她最初对二氮氧化物反应良好,但出现了剂量依赖性的ph。二氮氧化物停止治疗,改为奥曲肽、糖原储存病乳和胰高血糖素治疗。然而,维持稳定的血糖水平仍然具有挑战性。当医疗管理无效时,通常需要手术干预;然而,这种程序仅限于专门的设施。此外,胰腺切除术有很高的术后糖尿病风险。为了能够安全地重新引入二氮氧化物,我们通过左向右分流术手术关闭房间隔缺损,并将二氮氧化物治疗与抗ph药物联合使用。这种方法成功地控制了PH值,并取得了良好的血糖控制。
{"title":"Management strategy for congenital hyperinsulinism with atrial septal defect and diazoxide-induced pulmonary hypertension.","authors":"Sayuri Koizumi, Ikuma Musha, Koichi Toda, Hiroshi Kawana, Chikahiko Numakura, Katsuhiko Tabata, Takamasa Mizumoto, Taisuke Nabeshima, Takuro Kojima, Toshiki Kobayashi, Takaya Hoashi, Toru Kikuchi","doi":"10.1297/cpe.2024-0096","DOIUrl":"10.1297/cpe.2024-0096","url":null,"abstract":"<p><p>Congenital hyperinsulinism (CHI) is characterized by hypoglycemia caused by excessive insulin secretion. CHI is classified into two types: transient CHI, which resolves within 3-4 mo of birth, and persistent CHI, which persists beyond this period. Diazoxide, the first-line treatment for CHI, may cause pulmonary hypertension (PH) as a side effect. Here, we report the case of a 2-mo-old girl with CHI and an atrial septal defect who initially responded well to diazoxide but developed dose-dependent PH. Diazoxide was discontinued, and treatment was switched to octreotide, glycogen storage disease milk, and glucagon. However, maintaining stable blood glucose levels remained challenging. Surgical intervention is typically required when medical management is ineffective; however, such procedures are limited to specialized facilities. Additionally, pancreatic resection carries a high risk of postoperative diabetes. To enable the safe reintroduction of diazoxide, we surgically closed the atrial septal defect with a left-to-right shunt and combined diazoxide therapy with anti-PH medication. This approach successfully controlled PH and achieved good glycemic control.</p>","PeriodicalId":10678,"journal":{"name":"Clinical Pediatric Endocrinology","volume":"34 3","pages":"188-192"},"PeriodicalIF":1.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12236185/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144599624","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Osteogenesis imperfecta: pathogenesis, classification, and treatment. 成骨不全:发病机制、分类和治疗。
IF 1 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-07-01 Epub Date: 2025-03-31 DOI: 10.1297/cpe.2025-0009
Kosei Hasegawa

Osteogenesis imperfecta (OI) is a congenital skeletal disorder characterized by varying degrees of bone fragility and deformities. Extraskeletal manifestations, such as blue sclera, dentinogenesis imperfecta, growth disturbance, hearing impairment, and muscle weakness, occasionally accompany OI. Many genes have been identified as causative of OI, such as the type I collagen gene and genes involved in the folding, processing, and crosslinking of type I collagen molecules, osteoblast differentiation, and bone mineralization. According to the discovery of the causative gene of OI, nosology and classifications have also been revised and the "dyadic approach" based nomenclature according to the severity and each causative gene of OI was recently adopted. Intravenous or oral bisphosphonates have been administered to treat bone fragility in children with OI and a reduction in the frequency of bone fractures has been reported. However, despite the increase of bone mineral density, evidence of bone fracture prevention is limited. Recently, excessive transforming growth factor β signaling pathway and excessive endoplasmic reticulum stress have been reported as the pathogenesis of OI, and treatment strategies based on these pathogeneses have been developed. This review summarizes the molecular basis, transition of nosology and classification, status of bisphosphonate therapy, and development of treatment strategies.

成骨不全症(Osteogenesis imperfecta, OI)是一种先天性骨骼疾病,其特征是不同程度的骨骼脆弱和畸形。骨外表现,如蓝色巩膜、牙釉质发育不全、生长障碍、听力障碍和肌肉无力,偶尔会伴随成骨不全。许多基因已被确定为成骨不全的病因,如I型胶原蛋白基因和参与I型胶原蛋白分子的折叠、加工和交联、成骨细胞分化和骨矿化的基因。根据成骨不全致病基因的发现,对病种学和分类也进行了修订,最近采用了基于严重程度和每个成骨不全致病基因的“二元法”命名法。静脉注射或口服双膦酸盐已被用于治疗成骨不全儿童的骨脆性,并有报道称骨折的频率降低。然而,尽管骨密度增加,但预防骨折的证据有限。近年来,过度的转化生长因子β信号通路和过度的内质网应激被报道为成骨不全的发病机制,并基于这些发病机制制定了治疗策略。本文综述了双膦酸盐的分子基础、分类学和分类的转变、双膦酸盐治疗的现状以及治疗策略的发展。
{"title":"Osteogenesis imperfecta: pathogenesis, classification, and treatment.","authors":"Kosei Hasegawa","doi":"10.1297/cpe.2025-0009","DOIUrl":"10.1297/cpe.2025-0009","url":null,"abstract":"<p><p>Osteogenesis imperfecta (OI) is a congenital skeletal disorder characterized by varying degrees of bone fragility and deformities. Extraskeletal manifestations, such as blue sclera, dentinogenesis imperfecta, growth disturbance, hearing impairment, and muscle weakness, occasionally accompany OI. Many genes have been identified as causative of OI, such as the type I collagen gene and genes involved in the folding, processing, and crosslinking of type I collagen molecules, osteoblast differentiation, and bone mineralization. According to the discovery of the causative gene of OI, nosology and classifications have also been revised and the \"dyadic approach\" based nomenclature according to the severity and each causative gene of OI was recently adopted. Intravenous or oral bisphosphonates have been administered to treat bone fragility in children with OI and a reduction in the frequency of bone fractures has been reported. However, despite the increase of bone mineral density, evidence of bone fracture prevention is limited. Recently, excessive transforming growth factor β signaling pathway and excessive endoplasmic reticulum stress have been reported as the pathogenesis of OI, and treatment strategies based on these pathogeneses have been developed. This review summarizes the molecular basis, transition of nosology and classification, status of bisphosphonate therapy, and development of treatment strategies.</p>","PeriodicalId":10678,"journal":{"name":"Clinical Pediatric Endocrinology","volume":"34 3","pages":"152-161"},"PeriodicalIF":1.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12236168/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144599625","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A case of latent autoimmune diabetes in the young positive for zinc transporter 8 antibody with type 2 diabetes characteristics. 具有2型糖尿病特征的锌转运蛋白8抗体阳性青年潜伏性自身免疫性糖尿病1例。
IF 1 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-07-01 Epub Date: 2025-05-30 DOI: 10.1297/cpe.2024-0083
Takaaki Matsuda, Yoshinori Osaki, Nao Soma, Takayo Azuma, Aya Ezura, Yuta Mitani, Yuichi Kikuchi, Nako Matsumoto, Yuki Murayama, Yoko Sugano, Hitoshi Iwasaki, Bryan J Mathis, Motohiro Sekiya, Hitoshi Shimano

Latent autoimmune diabetes in the young (LADY), also known as slowly progressive insulin-dependent diabetes mellitus (SPIDDM), is a slowly progressive form of type 1 diabetes (T1D) characterized by positive islet-related autoantibodies and, typically, an initial type 2 diabetes (T2D) phenotype. Although approximately 10% of children with T2D have positive islet-related autoantibodies, reports on the clinical course of patients with LADY are limited. We present the case of a 17-yr-old female initially diagnosed with T2D based on a body mass index (BMI) of 27 kg/m2, obesity, and preserved endogenous insulin secretion. Notably, the glutamic acid decarboxylase antibody (GADA) test results fluctuated between weakly positive and negative. She developed diabetic ketosis 9 mo later, with a weak GADA titer and a high zinc transporter-8 antibody (Zn-T8A) titer, confirming autoimmune β-cell destruction consistent with T1D. Subsequent human leukocyte antigen (HLA) testing revealed the presence of the DRB1*15:02-DQB1*06:01 haplotype, which is considered protective against T1D. This case report details the clinical course of LADY, emphasizes close follow-up and re-evaluation of multiple islet-related autoantibodies in patients to distinguish LADY from T2D, and suggests that a protective HLA haplotype may have contributed to the slow onset despite high-titer Zn-T8A.

年轻人潜伏性自身免疫性糖尿病(LADY),也被称为缓慢进行性胰岛素依赖性糖尿病(SPIDDM),是一种缓慢进行性的1型糖尿病(T1D),其特征是胰岛相关自身抗体阳性,通常为初始2型糖尿病(T2D)表型。虽然大约10%的T2D患儿有胰岛相关自身抗体阳性,但关于LADY患者临床病程的报道有限。我们报告了一位17岁的女性,根据27 kg/m2的身体质量指数(BMI)、肥胖和内源性胰岛素分泌的保留,最初诊断为T2D。值得注意的是,谷氨酸脱羧酶抗体(GADA)检测结果在弱阳性和阴性之间波动。9个月后,患者出现糖尿病酮症,GADA滴度较弱,锌转运蛋白-8抗体(Zn-T8A)滴度较高,证实自身免疫性β细胞破坏与T1D一致。随后的人类白细胞抗原(HLA)检测显示存在DRB1*15:02-DQB1*06:01单倍型,该单倍型被认为对T1D具有保护作用。本病例报告详细介绍了LADY的临床病程,强调密切随访和重新评估患者的多种胰岛相关自身抗体,以区分LADY与T2D,并提示保护性HLA单倍型可能是导致高滴度Zn-T8A发病缓慢的原因。
{"title":"A case of latent autoimmune diabetes in the young positive for zinc transporter 8 antibody with type 2 diabetes characteristics.","authors":"Takaaki Matsuda, Yoshinori Osaki, Nao Soma, Takayo Azuma, Aya Ezura, Yuta Mitani, Yuichi Kikuchi, Nako Matsumoto, Yuki Murayama, Yoko Sugano, Hitoshi Iwasaki, Bryan J Mathis, Motohiro Sekiya, Hitoshi Shimano","doi":"10.1297/cpe.2024-0083","DOIUrl":"10.1297/cpe.2024-0083","url":null,"abstract":"<p><p>Latent autoimmune diabetes in the young (LADY), also known as slowly progressive insulin-dependent diabetes mellitus (SPIDDM), is a slowly progressive form of type 1 diabetes (T1D) characterized by positive islet-related autoantibodies and, typically, an initial type 2 diabetes (T2D) phenotype. Although approximately 10% of children with T2D have positive islet-related autoantibodies, reports on the clinical course of patients with LADY are limited. We present the case of a 17-yr-old female initially diagnosed with T2D based on a body mass index (BMI) of 27 kg/m<sup>2</sup>, obesity, and preserved endogenous insulin secretion. Notably, the glutamic acid decarboxylase antibody (GADA) test results fluctuated between weakly positive and negative. She developed diabetic ketosis 9 mo later, with a weak GADA titer and a high zinc transporter-8 antibody (Zn-T8A) titer, confirming autoimmune β-cell destruction consistent with T1D. Subsequent human leukocyte antigen (HLA) testing revealed the presence of the DRB1*15:02-DQB1*06:01 haplotype, which is considered protective against T1D. This case report details the clinical course of LADY, emphasizes close follow-up and re-evaluation of multiple islet-related autoantibodies in patients to distinguish LADY from T2D, and suggests that a protective HLA haplotype may have contributed to the slow onset despite high-titer Zn-T8A.</p>","PeriodicalId":10678,"journal":{"name":"Clinical Pediatric Endocrinology","volume":"34 3","pages":"193-199"},"PeriodicalIF":1.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12236175/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144599620","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Amplicon-based targeted next-generation sequencing using dried blood spots for 46,XY differences/disorders of sex development: Aiming for diagnosis by minimally invasive testing. 基于扩增子的新一代定向测序,利用干血点检测46,xy差异/性发育障碍:旨在通过微创检测进行诊断。
IF 1 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-07-01 Epub Date: 2025-04-04 DOI: 10.1297/cpe.2024-0081
Erika Uehara, Kazuhisa Akiba, Keiko Matsubara, Maki Fukami, Kanako Tanase-Nakao

Rapid genetic diagnosis of differences/disorders of sex development (DSD) through minimally invasive testing is desirable. In this study, we performed PCR amplicon-based next-generation sequencing (NGS) targeting AR and SRD5A2 using dried blood spots from 22 patients with 46,XY DSD. We compared the results with those of an outsourced capture-based NGS using venous blood-derived DNA. We successfully extracted DNA from the dried blood spots and obtained analysis results for 19 of the 22 cases within a minimum of seven days. The DNA quantity required was significantly lower for amplicon-based NGS using dried blood spots than for capture-based NGS using venous blood (median 8.7 ng vs. 1434.8 ng). We identified four single-nucleotide substitutions in SRD5A2 in 16 of the 19 cases. The results were consistent between the two NGS analyses and Sanger sequencing using venous blood, except for case 1. In this case, amplicon-based NGS using dried blood spots incorrectly identified a heterozygous SRD5A2 variant as homozygous, presumably due to allelic dropout. In conclusion, we demonstrated that amplicon-based NGS using dried blood spots allowed for rapid and minimally invasive genetic testing in patients with 46,XY DSD. However, optimizing DNA extraction from dried blood spots and validating detected variants using Sanger sequencing are necessary.

通过微创检测快速基因诊断性发育差异/障碍(DSD)是可取的。在这项研究中,我们利用22例46,xy DSD患者的干血斑,对AR和SRD5A2进行了基于PCR扩增子的下一代测序(NGS)。我们将结果与使用静脉血来源DNA的外包捕获NGS的结果进行了比较。我们成功地从干燥的血斑中提取DNA,并在至少7天内获得了22例中19例的分析结果。使用干血点的扩增子NGS所需的DNA量明显低于使用静脉血的捕获型NGS(中位数8.7 ng vs. 1434.8 ng)。我们在19例病例中的16例中发现了SRD5A2的4个单核苷酸替换。除病例1外,两次NGS分析和Sanger静脉血测序结果一致。在这种情况下,基于扩增子的NGS使用干燥的血斑错误地将杂合的SRD5A2变异识别为纯合的,可能是由于等位基因缺失。总之,我们证明了基于扩增子的NGS使用干血点可以快速和微创地检测46,xy DSD患者的基因。然而,优化从干血点提取DNA和使用Sanger测序验证检测到的变异是必要的。
{"title":"Amplicon-based targeted next-generation sequencing using dried blood spots for 46,XY differences/disorders of sex development: Aiming for diagnosis by minimally invasive testing.","authors":"Erika Uehara, Kazuhisa Akiba, Keiko Matsubara, Maki Fukami, Kanako Tanase-Nakao","doi":"10.1297/cpe.2024-0081","DOIUrl":"10.1297/cpe.2024-0081","url":null,"abstract":"<p><p>Rapid genetic diagnosis of differences/disorders of sex development (DSD) through minimally invasive testing is desirable. In this study, we performed PCR amplicon-based next-generation sequencing (NGS) targeting <i>AR</i> and <i>SRD5A2</i> using dried blood spots from 22 patients with 46,XY DSD. We compared the results with those of an outsourced capture-based NGS using venous blood-derived DNA. We successfully extracted DNA from the dried blood spots and obtained analysis results for 19 of the 22 cases within a minimum of seven days. The DNA quantity required was significantly lower for amplicon-based NGS using dried blood spots than for capture-based NGS using venous blood (median 8.7 ng vs. 1434.8 ng). We identified four single-nucleotide substitutions in <i>SRD5A2</i> in 16 of the 19 cases. The results were consistent between the two NGS analyses and Sanger sequencing using venous blood, except for case 1. In this case, amplicon-based NGS using dried blood spots incorrectly identified a heterozygous <i>SRD5A2</i> variant as homozygous, presumably due to allelic dropout. In conclusion, we demonstrated that amplicon-based NGS using dried blood spots allowed for rapid and minimally invasive genetic testing in patients with 46,XY DSD. However, optimizing DNA extraction from dried blood spots and validating detected variants using Sanger sequencing are necessary.</p>","PeriodicalId":10678,"journal":{"name":"Clinical Pediatric Endocrinology","volume":"34 3","pages":"172-179"},"PeriodicalIF":1.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12236167/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144599621","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A case of congenital hypopituitarism harboring a nonsense variant in the LHX4 gene. 一例先天性垂体功能减退症,携带LHX4基因无意义变异。
IF 1 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-07-01 Epub Date: 2025-04-05 DOI: 10.1297/cpe.2025-0006
Mikiko Koizumi, Yuri Etani, Saori Kinoshita, Natsuko Yamazaki, Nobuhiko Okamoto, Shinobu Ida, Masanobu Kawai
{"title":"A case of congenital hypopituitarism harboring a nonsense variant in the <i>LHX4</i> gene.","authors":"Mikiko Koizumi, Yuri Etani, Saori Kinoshita, Natsuko Yamazaki, Nobuhiko Okamoto, Shinobu Ida, Masanobu Kawai","doi":"10.1297/cpe.2025-0006","DOIUrl":"10.1297/cpe.2025-0006","url":null,"abstract":"","PeriodicalId":10678,"journal":{"name":"Clinical Pediatric Endocrinology","volume":"34 3","pages":"200-203"},"PeriodicalIF":1.0,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12236172/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144599619","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Clinical Pediatric Endocrinology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1